Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Kaposi | 7 | 2023 | 187 | 1.730 |
Why?
|
| Histiocytosis, Langerhans-Cell | 3 | 2019 | 261 | 1.270 |
Why?
|
| Hodgkin Disease | 2 | 2023 | 1429 | 0.830 |
Why?
|
| Maternal Exposure | 3 | 2019 | 160 | 0.800 |
Why?
|
| Air Pollutants | 3 | 2019 | 139 | 0.780 |
Why?
|
| Insurance Coverage | 4 | 2010 | 256 | 0.760 |
Why?
|
| Residence Characteristics | 3 | 2021 | 348 | 0.750 |
Why?
|
| Insurance, Health | 3 | 2010 | 250 | 0.700 |
Why?
|
| Air Pollution, Indoor | 2 | 2019 | 39 | 0.700 |
Why?
|
| Vehicle Emissions | 1 | 2019 | 29 | 0.690 |
Why?
|
| Case-Control Studies | 12 | 2023 | 6100 | 0.650 |
Why?
|
| Hypospadias | 4 | 2020 | 77 | 0.640 |
Why?
|
| Women's Health | 2 | 2010 | 205 | 0.640 |
Why?
|
| Optic Nerve Glioma | 1 | 2018 | 31 | 0.640 |
Why?
|
| Smad6 Protein | 1 | 2017 | 14 | 0.630 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2018 | 79 | 0.620 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2019 | 5539 | 0.590 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2016 | 70 | 0.570 |
Why?
|
| Registries | 3 | 2020 | 2170 | 0.570 |
Why?
|
| HIV Infections | 8 | 2023 | 2134 | 0.560 |
Why?
|
| Air Pollutants, Radioactive | 1 | 2015 | 6 | 0.550 |
Why?
|
| Radon | 1 | 2015 | 11 | 0.550 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2021 | 2796 | 0.530 |
Why?
|
| Child | 28 | 2023 | 29154 | 0.530 |
Why?
|
| Genome-Wide Association Study | 6 | 2020 | 2265 | 0.510 |
Why?
|
| Medically Uninsured | 3 | 2010 | 102 | 0.460 |
Why?
|
| Herpesvirus 8, Human | 3 | 2023 | 102 | 0.440 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1046 | 0.420 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2019 | 4549 | 0.410 |
Why?
|
| Parents | 1 | 2018 | 998 | 0.390 |
Why?
|
| Texas | 9 | 2020 | 6311 | 0.370 |
Why?
|
| Child, Preschool | 15 | 2021 | 16273 | 0.370 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2016 | 1039 | 0.370 |
Why?
|
| Poverty | 2 | 2010 | 471 | 0.350 |
Why?
|
| Health Status Indicators | 1 | 2010 | 224 | 0.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2021 | 268 | 0.330 |
Why?
|
| Adolescent | 19 | 2023 | 31252 | 0.320 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2023 | 502 | 0.300 |
Why?
|
| Health Services Accessibility | 2 | 2010 | 761 | 0.290 |
Why?
|
| Anemia | 2 | 2023 | 689 | 0.290 |
Why?
|
| Lymphoma | 1 | 2015 | 1467 | 0.290 |
Why?
|
| Female | 27 | 2023 | 141928 | 0.260 |
Why?
|
| Adult | 17 | 2023 | 77950 | 0.260 |
Why?
|
| Tanzania | 2 | 2023 | 68 | 0.260 |
Why?
|
| Infant | 12 | 2023 | 13310 | 0.260 |
Why?
|
| Humans | 39 | 2023 | 261506 | 0.250 |
Why?
|
| SEER Program | 2 | 2018 | 1000 | 0.250 |
Why?
|
| Male | 23 | 2023 | 123000 | 0.240 |
Why?
|
| Incidence | 4 | 2018 | 5673 | 0.240 |
Why?
|
| DNA Methylation | 3 | 2020 | 2669 | 0.240 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 598 | 0.240 |
Why?
|
| Endogenous Retroviruses | 1 | 2023 | 41 | 0.230 |
Why?
|
| Kasabach-Merritt Syndrome | 1 | 2023 | 16 | 0.220 |
Why?
|
| MicroRNAs | 1 | 2016 | 2947 | 0.220 |
Why?
|
| Cerebellar Neoplasms | 2 | 2017 | 434 | 0.210 |
Why?
|
| Extremities | 1 | 2023 | 303 | 0.210 |
Why?
|
| Minority Groups | 2 | 2018 | 322 | 0.210 |
Why?
|
| Infant, Newborn | 7 | 2021 | 8223 | 0.210 |
Why?
|
| Medulloblastoma | 2 | 2017 | 540 | 0.200 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 1283 | 0.200 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 1225 | 0.200 |
Why?
|
| Thrombocytosis | 1 | 2022 | 121 | 0.200 |
Why?
|
| Risk Factors | 8 | 2023 | 17523 | 0.200 |
Why?
|
| United States | 7 | 2023 | 15433 | 0.200 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 129 | 0.200 |
Why?
|
| Exome | 2 | 2017 | 1239 | 0.200 |
Why?
|
| California | 3 | 2010 | 208 | 0.200 |
Why?
|
| Young Adult | 9 | 2021 | 21445 | 0.190 |
Why?
|
| Women | 2 | 2010 | 27 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 362 | 0.180 |
Why?
|
| Odds Ratio | 3 | 2019 | 2316 | 0.180 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 147 | 0.170 |
Why?
|
| Malawi | 4 | 2023 | 378 | 0.170 |
Why?
|
| Malnutrition | 1 | 2022 | 218 | 0.170 |
Why?
|
| Diacylglycerol Kinase | 1 | 2019 | 23 | 0.170 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 6915 | 0.170 |
Why?
|
| Metals, Heavy | 1 | 2019 | 32 | 0.170 |
Why?
|
| Social Class | 1 | 2020 | 310 | 0.160 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 366 | 0.160 |
Why?
|
| Health Care Surveys | 2 | 2010 | 430 | 0.160 |
Why?
|
| Air Pollution | 1 | 2019 | 87 | 0.160 |
Why?
|
| Human papillomavirus 18 | 1 | 2017 | 43 | 0.160 |
Why?
|
| Neuroblastoma | 1 | 2023 | 686 | 0.150 |
Why?
|
| Interleukin-6 | 2 | 2019 | 1038 | 0.150 |
Why?
|
| Herpesviridae Infections | 1 | 2018 | 175 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 846 | 0.150 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 122 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2020 | 291 | 0.150 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2016 | 69 | 0.140 |
Why?
|
| Viral Load | 1 | 2018 | 493 | 0.140 |
Why?
|
| Mexico | 1 | 2016 | 259 | 0.140 |
Why?
|
| Premature Birth | 1 | 2021 | 407 | 0.140 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 256 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 677 | 0.140 |
Why?
|
| Inhalation Exposure | 1 | 2015 | 41 | 0.130 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 184 | 0.130 |
Why?
|
| Housing | 1 | 2015 | 61 | 0.130 |
Why?
|
| Leukemia | 1 | 2023 | 1635 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2010 | 1819 | 0.120 |
Why?
|
| Acute Disease | 1 | 2019 | 2422 | 0.120 |
Why?
|
| Pregnancy | 4 | 2021 | 7573 | 0.120 |
Why?
|
| Genetic Testing | 2 | 2021 | 1589 | 0.120 |
Why?
|
| Family | 1 | 2017 | 736 | 0.110 |
Why?
|
| Databases, Genetic | 2 | 2023 | 745 | 0.110 |
Why?
|
| Lamivudine | 2 | 2022 | 28 | 0.110 |
Why?
|
| Risk | 1 | 2015 | 1972 | 0.100 |
Why?
|
| Middle Aged | 7 | 2018 | 86204 | 0.100 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1910 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 1294 | 0.090 |
Why?
|
| Birth Weight | 2 | 2023 | 374 | 0.090 |
Why?
|
| Cytokines | 1 | 2019 | 2809 | 0.090 |
Why?
|
| Marital Status | 1 | 2010 | 98 | 0.090 |
Why?
|
| Cisplatin | 1 | 2017 | 2432 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2018 | 9244 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 3022 | 0.090 |
Why?
|
| Genome, Human | 1 | 2018 | 1869 | 0.090 |
Why?
|
| Genotype | 4 | 2019 | 4109 | 0.090 |
Why?
|
| Income | 1 | 2010 | 222 | 0.090 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2008 | 5 | 0.090 |
Why?
|
| Office Visits | 1 | 2009 | 97 | 0.090 |
Why?
|
| Mothers | 2 | 2023 | 410 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 980 | 0.080 |
Why?
|
| Employment | 1 | 2009 | 129 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 2291 | 0.080 |
Why?
|
| Educational Status | 1 | 2010 | 397 | 0.080 |
Why?
|
| Blood Cells | 1 | 2019 | 127 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2022 | 37905 | 0.080 |
Why?
|
| Gestational Age | 2 | 2023 | 1069 | 0.080 |
Why?
|
| Health Surveys | 1 | 2010 | 402 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 105 | 0.080 |
Why?
|
| Vaginal Smears | 1 | 2009 | 192 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 5159 | 0.080 |
Why?
|
| Obesity | 2 | 2010 | 2884 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 1833 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 552 | 0.070 |
Why?
|
| CpG Islands | 2 | 2020 | 633 | 0.070 |
Why?
|
| Health Status | 1 | 2009 | 590 | 0.070 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 1084 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 4821 | 0.060 |
Why?
|
| Mammography | 1 | 2009 | 1010 | 0.060 |
Why?
|
| Aged | 3 | 2018 | 70117 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2017 | 5270 | 0.060 |
Why?
|
| Nevirapine | 1 | 2022 | 17 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2009 | 1000 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 266 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2010 | 2203 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2022 | 297 | 0.050 |
Why?
|
| Exercise | 1 | 2009 | 1183 | 0.050 |
Why?
|
| Platelet Count | 1 | 2022 | 490 | 0.050 |
Why?
|
| Causality | 1 | 2021 | 178 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2023 | 671 | 0.050 |
Why?
|
| Smoking | 1 | 2009 | 2440 | 0.050 |
Why?
|
| Virus Replication | 1 | 2023 | 709 | 0.050 |
Why?
|
| Weight Gain | 1 | 2023 | 464 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2021 | 32848 | 0.050 |
Why?
|
| Prognosis | 3 | 2022 | 21713 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 263 | 0.040 |
Why?
|
| Arkansas | 1 | 2019 | 58 | 0.040 |
Why?
|
| Hazardous Substances | 1 | 2019 | 27 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 342 | 0.040 |
Why?
|
| Lymphadenopathy | 1 | 2019 | 90 | 0.040 |
Why?
|
| Endemic Diseases | 1 | 2018 | 67 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 367 | 0.040 |
Why?
|
| Unsafe Sex | 1 | 2017 | 21 | 0.040 |
Why?
|
| Virus Integration | 1 | 2017 | 76 | 0.040 |
Why?
|
| Guatemala | 1 | 2017 | 67 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 148 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 10331 | 0.040 |
Why?
|
| Virus Activation | 1 | 2018 | 228 | 0.040 |
Why?
|
| Neoplasms | 1 | 2023 | 15193 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 966 | 0.040 |
Why?
|
| Canada | 1 | 2017 | 429 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2017 | 153 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 14889 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2017 | 694 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2017 | 328 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 12873 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 4314 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 1399 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 2803 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 3441 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 2437 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 2086 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 3260 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9180 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 3101 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4053 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 15179 | 0.020 |
Why?
|
| Health Care Reform | 1 | 2008 | 68 | 0.020 |
Why?
|
| Child Health Services | 1 | 2008 | 82 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12221 | 0.020 |
Why?
|
| Forecasting | 1 | 2008 | 694 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 6295 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 13658 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 4654 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 5377 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 14289 | 0.010 |
Why?
|
PECKHAM-GREGORY's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(197)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_